Delivery Order SPE2DB22D1002-SPE2DB24FKSY0
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a $2,058.10 firm-fixed-price delivery order for the supply of Cetirizine HCl 5 mg tablets. The award was made by the Defense Logistics Agency (DLA), which is a defense agency. The contract has an ultimate completion date of June 12, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued...
- This federal contract award was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,172.80 firm fixed-price delivery order is for the supply of Cetirizine HCL 5 mg tablets, with a completion date of December 18, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,568.90, is a delivery order for the supply of Cetirizine HCL 10 mg tablets. The contract has an ultimate completion date of March 21, 2025 and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Cetirizine Hydrochloride 5 mg tablets. The contract has a ceiling value of $1,672.40 and an ultimate completion date of April 26, 2024. This contract is not designated as a set-aside award. Amerisourcebergen Drug Corp has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00...
- This federal contract award, valued at $2,228.25, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The contract is for the delivery of Cetirizine HCL 5 mg tablets in quantities of 100s, with a completion date of August 6, 2024. This appears to be a firm fixed-price delivery order contract, and there is no set-aside designation mentioned. Amerisourcebergen Drug Corp holds several Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,197.91 firm-fixed-price delivery order is for the supply of 4,562,549,817 units of Cetirizine HCL 5 mg tablets. The contract has an ultimate completion date of October 23, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was issued by the Defense Logistics Agency (DLA) for the delivery of 4,562,926,968 tablets of the drug Cetirizine HCl 5 mg. The contract has a firm fixed price of $12,461.65 and a completion date of November 29, 2023. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,048.75 firm fixed-price delivery order contract is for the supply of Cetirizine HCL 10 mg tablets. The contract is not designated as a set-aside and serves as a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
- This federal contract award, valued at $4,702.71, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,073,284 units of Cetirizine HCL 10 mg tablets, a prescription medication, with a completion date of April 30, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,108.38 firm fixed-price delivery order is for the supply of 4,562,252 units of Cetirizine HCL 10 mg tablets. The award has a completion date of September 21, 2023 and was made under the company's $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical, which serves as a primary vehicle for...
- SPE2DB22D1002Indefinite Delivery Contract
- SPE2DB22D1002-SPE2DB24FKSY0Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The Delivery Order contract, valued at $1,188.32, is for the supply of Cetirizine HCL 5 mg Tablets in 100-count packages. The contract has an ultimate completion date of October 17, 2023, and is a Firm Fixed Price type. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which is a for-profit organization. This contract award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating it was awarded through full and open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 10/16/23 |